Senior Team

Tom Richardson

Chief Executive Officer

Tom joined Hanson Wade in 2009 as one of the first full time hires. Having graduated from Emmanuel College, Cambridge with a degree in history, he was responsible for marketing of the first Hanson Wade events and built the foundation of the company’s technology platform.  Tom now holds the role of CEO with a focus on product quality, company culture and scalable process. His priority is building a first class team and giving them the best opportunity to produce outstanding results.

Tom Richardson
Phil Clark

Phil Clark

Chief Commercial Officer

Phil joined Hanson Wade in 2014 as the Commercial Director. Phil brought 15 years of sales leadership experience to the business where he had specialised in building large, high performing sales departments. Initially tasked with growing the capability of the sponsorship sales function his remit expanded to include delegate sales in January 2016. He now works in the senior team as the Chief Commercial Officer and is responsible for setting and executing Hanson Wade’s commercial strategy.

Darren Francis

Chief Financial Officer

Darren joined Hanson Wade in January 2010 and is the company’s Chief Financial Officer.  He is a Fellow of the Association of Chartered Certified Accountants (FCCA), having qualified with Royal & Sun Alliance, a FTSE 100 company, where he spent the first 17 years of his career. Prior to joining Hanson Wade he has held senior finance roles at F&C Asset Management, PLUS Markets Group, where he was CFO and a member of the Executive Board and The Phoenix Group.

Darren Francis

Hannah McCulloch

Marketing Director

Hannah has been managing marketing teams and projects in the conference industry for 14 years.

During her career she has focussed on process, analysis and strategy development. She joined the team in 2016 from i2i events group where she had been Head of Marketing for the large sale conference division. Hannah graduated from the University of the West of England with a first-class honours degree in marketing.

Matthew Turner

Managing Director & Joint Head of Life Sciences

Matthew Turner, Managing Director and Joint-Head of Life Sciences, graduated from Nottingham University with a degree in Biology in 2010 and joined Hanson Wade in 2013. With a mandate to identify emerging sectors within the life science, and more recently Agriculture industries, Matthew specialises in novel topic generation, commercial event validation and portfolio development of existing and future brands. He continues to nurture and train the next generation of conference producer and is responsible for the strategic growth and product quality of life science conferences. 

James Eslea MacDonald

James Eslea MacDonald

Managing Director & Joint Head of Life Sciences

James joined Hanson Wade in 2009 after completion of his Masters degree in Biochemistry at the University of Sheffield. Having started as a Conference Producer, James is now Managing Director and Joint-Head of Life Sciences specialising in drug discovery and therapeutic R&D conferences. In addition to validating new topic angles and market opportunities, he is passionate about building the internal process and infrastructure to support the product strategy of Primary Insight, First.

Gareth Pearce

Managing Director, LEAP

Gareth established and is responsible for developing the LEAP business within Hanson Wade.  LEAP helps change how HR works in the world's most forward-thinking companies. Gareth has successfully built and grown information businesses in the US, Europe, Asia and the Middle East during a 15 year entrepreneurial career. He holds a first class degree in Politics and earned a postgraduate Certificate in International Business Practice from the Mountbatten Institute in New York.

Andy Cook - GreyScale

Andy Cook

Director of Data Products, Beacon

Andy joined Hanson Wade in 2016 to lead Hanson Wade’s development of business intelligence and data products. He brings a wealth of experience having created and developed business intelligence services with  Thomson Reuters in life sciences, GlobalData plc in risk management and Euromoney plc in asset management. After gaining an undergraduate degree in Physics and Chemistry, Andy switched to cancer research for his post-graduate studies.